PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Neurology, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Pulmonary & Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/phar.2524
?:hasPublicationType
?:journal
  • Pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33835512
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.28
?:rankingScore_hIndex
  • 97
is ?:relation_isRelatedTo_publication of
?:title
  • Use of Remdesivir in Myasthenia gravis and COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all